FDA greenlights GE SPECT agent for Parkinson's
Links shared publicly online about this topic.
- 579total visits
FDA greenlights GE SPECT agent for Parkinson's
The FDA has approved GE Healthcare--™s DaTscan (Ioflupane I 123 Injection), a radiopharmaceutical agent intended for use with SPECT imaging, for the detection of dopamine transporters (DaT) in the brains of adult patients with suspected Parkinsonian syndromes.
View full resource at healthimaging.com
Tags: Brain, Parkinson's Disease, Disease and Condition, Healthcare, FDA
Most Recently Shared on January 15, 2011 at 4:27 pm By:
FDA greenlights GE SPECT agent for Parkinson's - The FDA has approved GE Healthcare’s DaTscan (Ioflupane I 123 Inje... http://ow.ly/1aSFTN
Advertisement
